Editorial: Response to March 2003 Article in Quest

Mar 28, 2003 | EDITORIALS

By: Marylyn House posted on: March 28, 2003 The following correspondence is in response to the Pompe disease research article that was published in the March 2003 issue of “Quest” an MDA publication. It includes emails sent over the GSDnet during February-March 2003,...

Genzyme General Begins Enrolling Patients in Pompe Disease Study

Mar 20, 2003 | NEWS

CAMBRIDGE, Mass – Genzyme General (Nasdaq: GENZ), a division of Genzyme Corp., announced today that it has begun enrolment in a clinical trial evaluating the use of its Myozyme™  recombinant human acid alpha -Glucosidase enzyme as a potential treatment for Pompe...